09.12.2009 • News

Arkema Q1 Sales €1.092 Billion

Arkema announced Q1 sales of €1.092 billion. Q1 Ebitda fell by 64 % to €57 million. Visibility remains very low, and the company cannot see any noticeable improvement in the economic ­environment. Arkema says it confirmed its target to generate a positive free cash flow in 2009 and also confirmed its target to reduce fixed costs by
€550 million in 2010 compared to 2005.

From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

Interview

The UK Chemical Supply Chain
Trade and Competitiveness

The UK Chemical Supply Chain

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.